Patents by Inventor Bertrand Cosson

Bertrand Cosson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides used for treating cancers and, in particular, chronic lymphoid leukaemia
    Patent number: 9745357
    Abstract: The invention relates to the A1 peptide of the sequence RRKYGRDFLLRF, as well as to certain variants thereof, for treating cancers, in particular malignant hematopoietic diseases, and more particularly for treating chronic lymphoid leukaemia.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: August 29, 2017
    Assignees: Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire de Brest, Universite de Bretagne Occidentale, Universite Pierre et Marie Curie (Paris 6)
    Inventors: Bertrand Cosson, Hussam Saad, Patrick Cormier, Christian Berthou, Mirjam Czjzek
  • POSITIVE CYTOMODULINES TO IMPROVE BIOREACTOR PRODUCTIVITY
    Publication number: 20130004991
    Abstract: The present invention relates to the activation of the protein synthesis by controlling the post-transcriptional steps of mRNA translation into proteins. A polypeptide is provided, which is capable of activating said protein translation. The principal industrial application of the invention is the control of recombinant protein production in cultured cells including in bioreactors.
    Type: Application
    Filed: July 19, 2007
    Publication date: January 3, 2013
    Inventors: Bertrand Cosson, Vincent Legagneux, Luc Paillard, Howard Beverley Osborne, Didier Poncet, Cécile Keryer-Bibens
  • Peptides Used for Treating Cancers and, in Particular, Chronic Lymphoid Leukaemia
    Publication number: 20120172315
    Abstract: The invention relates to the A1 peptide of the sequence RRKYGRDFLLRF, as well as to certain variants thereof, for treating cancers, in particular malignant hematopoietic diseases, and more particularly for treating chronic lymphoid leukaemia.
    Type: Application
    Filed: March 5, 2010
    Publication date: July 5, 2012
    Inventors: Bertrand Cosson, Hussam Saad, Patrick Cormier, Christian Berthou, Mirjam Czjzek
  • Peptide protein translation inhibitor and the use thereof for protein translation control
    Patent number: 7863413
    Abstract: A peptide protein translation inhibitor has a size greater than 250 amino acids and it includes an amino acid sequence which is at least for 85% identical to an amino acid sequence SEQ ID No 1. It also relates to a fusion polypeptide which specifically inhibits an interesting target polynucleotide translation, in which the polypeptide includes the above defined inhibiting peptide fused with a RNA binding protein.
    Type: Grant
    Filed: July 20, 2004
    Date of Patent: January 4, 2011
    Assignees: Centre National de la Recherche Scientifique (CNRS), Universite de Rennes 1
    Inventors: Bertrand Cosson, Luc Paillard, Vincent Legagneux, Howard Osborne
  • Peptide protein translation inhibitor and the use thereof for protein translation control
    Publication number: 20070105764
    Abstract: A peptide protein translation inhibitor has a size greater than 250 amino acids and it includes an amino acid sequence which is at least for 85% identical to an amino acid sequence SEQ ID No1. It also relates to a fusion polypeptide which specifically inhibits an interesting target polynucleotide translation, in which the polypeptide includes the above defined inhibiting peptide fused with a RNA binding protein.
    Type: Application
    Filed: July 20, 2004
    Publication date: May 10, 2007
    Inventors: Bertrand Cosson, Luc Paillard, Vincent Legagneux, Howard Osborne